JUSTIN KLAMERUS was named chief quality officer and executive vice president for community-based programs at the Barbara Ann Karmanos Cancer Institute.
BAYLOR COLLEGE OF MEDICINE, CHI St. Luke's Health and the Texas Heart Institute have expanded their educational, clinical and research affiliations in conjunction with Catholic Health Initiatives, which sponsors and operates the newly named CHI St. Luke's Health.
REGENERON PHARMACEUTICALS Inc. and Geisinger Health System announced a research collaboration focused on studying the genetic determinants of human disease.
MD ANDERSON CANCER CENTER and Pfizer will collaborate in the development of immune-based approaches to cancer treatment, the first such agreement made through MD Anderson's Moon Shots Program immunotherapy platform.
DMITRI ALDEN was named an Honorary Foreign Member of the French National Academy of Surgery. He will be officially recognized at the academy's 2014 Solemn Ceremony Jan. 22 in Paris.
BARBARA ANN BURTNESS was named clinical research program leader of the Head and Neck Cancers Program at Smilow Cancer Hospital at Yale-New Haven and co-director of the Developmental Therapeutics Research Program for Yale Cancer Center. She will become a professor of medicine in medical oncology and will begin her appointment April 1.
J. ROBERT BECK was named deputy director and chief academic and administrative officer of Fox Chase Cancer Center.
HAROLD VARMUS, director of the NCI and co-recipient of a Nobel Prize for research into the genetic basis of cancer, received the Medal of Honour from the International Agency for Research on Cancer in France.
RICHARD GANNOTTA was named president of Northwestern Memorial Hospital and senior vice president of Northwestern Memorial HealthCare, effective Feb. 10.
GARY SCHWARTZ was named chief of the Division of Hematology/Oncology at NewYork-Presbyterian/Columbia University Medical Center. He will also serve as associate director for research of the Herbert Irving Comprehensive Cancer Center.
